United Therapeutics

Yahoo Finance • 19 days ago

United Therapeutics Corp (NASDAQ:UTHR): A Prime Value Investing Candidate with Strong Fundamentals

Value investing, a strategy established by Benjamin Graham and famously used by Warren Buffett and Charlie Munger, involves finding stocks trading for less than their intrinsic value. This method looks for companies with good fundamentals... Full story

Yahoo Finance • 20 days ago

Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks edged higher late Friday afternoon with the NYSE Health Care Index edging up 0.1% PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 20 days ago

Sector Update: Health Care Stocks Rise Friday Afternoon

Health care stocks advanced Friday afternoon, with the NYSE Health Care Index up 0.2% and the Health PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 20 days ago

MannKind's Plan of Increasing Revenue Base, Advancing Potential Pipeline Enhances its Value Creation, Oppenheimer Says

MannKind's (MNKD) game plan of enhancing its revenue base, while also advancing a potential pipeline PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 22 days ago

Morning Movers: United Therapeutics surges after TETON-2 met primary endpoint

Markets reopened after the Labor Day break on softer footing, with futures tied to the major indexes pointing lower. Investors are balancing several pressures at once: gold prices have surged to fresh record highs above $3,550 an ounce, si... Full story

Yahoo Finance • 23 days ago

Stocks making the biggest midday moves: Frontier Group, Kraft Heinz, Biogen and more

Check out the companies making the biggest moves in midday trading: Frontier Group — Shares of the budget airline carrier shot up more than 13% in the wake of rival Spirit Airlines' bankruptcy filing on Friday. Humana — Shares of the healt... Full story

Yahoo Finance • 23 days ago

Why United Therapeutics Catapulted 38%, Pulling Insmed, Liquidia With It

United Therapeutics stock catapulted Tuesday, pulling shares of rivals Insmed and Liquidia higher, on positive test results in IPF. Continue Reading View Comments... Full story

Yahoo Finance • 26 days ago

Why MannKind (MNKD) Is Up 11.7% After Expanding Technosphere Partnership With United Therapeutics

On August 24, 2025, United Therapeutics announced an amendment to its license and collaboration agreement with MannKind, expanding the deal to cover a new development product formulated using MannKind’s Technosphere platform and triggering... Full story

Yahoo Finance • 29 days ago

MannKind rises as United Therapeutics exercises option for second inhalational drug

[Collaboration concept. Colored threads are connected together and the inscription.] designer491/iStock via Getty Images * MannKind Corporation (NASDAQ:MNKD [https://seekingalpha.com/symbol/MNKD]) added ~10% in the morning hours on Wedn... Full story

Yahoo Finance • 29 days ago

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

DANBURY, Conn. and BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) --  MannKind Corporation (Nasdaq: MNKD) today announced that United Therapeutics Corporation (Nasdaq: UTHR) has exercised its option—granted under the companies’ 2018 license and... Full story

Yahoo Finance • 29 days ago

United Therapeutics Corp. (NASDAQ:UTHR) Embodies Peter Lynch's GARP Strategy

In the world of long-term investing, few strategies have shown as much practical success as the approach supported by Peter Lynch. His methodology, detailed in _One Up on Wall Street_, highlights finding companies with solid growth potenti... Full story

Yahoo Finance • last month

UNITED THERAPEUTICS CORP (NASDAQ:UTHR) – A Prime Value Investment with Strong Fundamentals and Undervalued Potential

Value investing focuses on finding stocks priced below their true worth while having solid financial foundations. The approach, based on Benjamin Graham’s ideas, looks for firms with good earnings, stable finances, and room to grow, but tr... Full story

Yahoo Finance • 2 months ago

UNITED THERAPEUTICS CORP (NASDAQ:UTHR) Excels as a High-Quality Pick in the Caviar Cruise Stock Screen

The Caviar Cruise stock screening strategy is designed to find high-quality companies suitable for long-term investment. Based on quality investing principles, this method looks for firms with steady revenue and profit growth, high returns... Full story

Yahoo Finance • 2 months ago

Why UNITED THERAPEUTICS CORP (NASDAQ:UTHR) Fits Peter Lynch’s Growth at a Reasonable Price (GARP) Strategy

Peter Lynch’s investment strategy, as described in _One Up on Wall Street_, centers on finding companies with steady growth at fair prices, commonly known as the Growth at a Reasonable Price (GARP) method. The approach highlights solid fun... Full story

Yahoo Finance • 2 months ago

United Therapeutics outlines $1B share repurchase and 12% revenue growth while advancing TETON 2 data catalyst

Earnings Call Insights: United Therapeutics (UTHR) Q2 2025 MANAGEMENT VIEW * Martine A. Rothblatt, CEO, highlighted, "United Therapeutics has achieved another record quarter of earnings, marking 12 consecutive quarters of double-digit... Full story

Yahoo Finance • 2 months ago

United Therapeutics GAAP EPS of $6.41 misses by $0.51, revenue of $798.6M misses by $5.05M

* United Therapeutics press release [https://seekingalpha.com/pr/20182259-united-therapeutics-corporation-reports-record-second-quarter-2025-financial-results] (NASDAQ:UTHR [https://seekingalpha.com/symbol/UTHR]): Q2 GAAP EPS of $6.41 mi... Full story

Yahoo Finance • 2 months ago

United Therapeutics EVP Mahon sells $3.3m in shares

Paul A. Mahon, Executive Vice President and General Counsel at United Therapeutics Corp (NASDAQ:UTHR), sold 11,000 shares of common stock on July 24, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The sal... Full story

Yahoo Finance • 2 months ago

United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., July 16, 2025--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its second quarter 2025 financial results before the market opens on Wedn... Full story

Yahoo Finance • 2 months ago

Liquidia Corp: chief human resource officer Krepp sells $38k in stock

Liquidia Corp (NASDAQ:LQDA), a $1.24 billion market cap biotech company, saw its Chief Human Resource Officer Sarah Krepp sell 2,673 shares of common stock on July 14, 2025, at a price of $14.28, for a total transaction value of $38,170. T... Full story

Yahoo Finance • 2 months ago

Liquidia Receives $50M from HCRx, Accelerates YUTREPIA’s Commercial Launch Following Favorable Court Ruling

Liquidia Corporation (NASDAQ:LQDA) is one of the best low priced pharma stocks to buy now. On June 24, Liquidia announced the receipt of an additional $50 million from Healthcare Royalty/HCRx. The funding followed the US District Court for... Full story